Telecobalt machines found lying idle for months: CAG
Inordinate delay in undertaking turnkey works resulted in non-installation of telecobalt machines - the new imported machines delivered at Dharmapuri and Tiruvannamalai GMCHs were lying idle for 15 months and 36 months respectively and the machine for Pudukkottai GMCH had reached Chennai Port in November 2021 but was not delivered to the hospital as of June 2024.
In its audit report (compliance audit) for the year ending March 2023 that was tabled in the Assembly, the CAG said that to ensure sufficient treatment facilities for patients diagnosed with cancer, the National Health Mission sanctioned ₹57 crore in three installments (in 2018 and 2019) to the Tamil Nadu Medical Services Corporation (TNMSC) for replacement of telecobalt machines in 10 GMCHs and for establishing four new telecobalt centres with bunkers in four GMCHs. In addition, the State government, in 2017, sanctioned ₹3 crore for purchase of a new cobalt therapy unit to Government Arignar Anna Memorial Cancer Hospital, Karapettai.
The TNMSC placed orders for supply and installation of the machines in 15 medical institutions of which 10 were commissioned and patient treatment commenced between August 2021 and October 2023. In the remaining institutions, machines supplied to four hospitals - Rajiv Gandhi Government General Hospital, GMCHs in Tiruvannamalai, Dharmapuri and Karapettai facility - between February 2021 and March 2023 - were not installed, while the machine for GMCH Pudukottai was not supplied till June 2024.
It also observed that TNMSC had failed in ensuring supply of the Treatment Planning System - an essential part of radiation treatment planning - by the supplier resulting in non-commencement of life-saving treatment for patients in five institutions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
10 hours ago
- The Hindu
40 products, 3 firms blacklisted in two years by T.N. Medical Services Corporation
In two years, the Tamil Nadu Medical Services Corporation (TNMSC) has blacklisted 40 products - drugs and injections - and three firms primarily for failing to meet quality control norms. According to data from TNMSC, an organisation that was set up to streamline the procurement, storage and distribution of essential drugs for government hospitals, 22 products were blacklisted for quality failures during 2023-2024. During 2024-2025, 26 products were blacklisted, of which 22 were quality-related and four for non-execution of purchase orders. A total of 14 products were blacklisted so far in 2025, all related to quality failures. Firm-wise, TNMSC blacklisted five firms during 2023-2024 (two for non-execution of purchase orders and three on quality grounds. While two firms were blacklisted during 2024-2025, one was blacklisted so far this year on quality grounds. Also Read: Not business as usual: On upholding India's reputation for quality drugs Year Number of blacklisted firms Reasons Number of products blacklisted Reasons 2023-2024 5 2 for non execution of purchase orders; 3 on quality grounds 22 All related to quality failures 2024-2025 2 On quality grounds 26 22 quality related 4 non execution of purchase orders 2025 (till date) 1 On quality grounds 14 All related to quality failures How quality checks are performed Officials of TNMSC said that quality checks on medicines are conducted as per the relevant pharmacopoeia (such as Indian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopoeia) at their entry level at warehouses through NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited empanelled laboratories. In case of any adverse reports from empanelled laboratories, the same drugs are re-tested at government laboratories in the State - laboratories at Teynampet and Guindy. Presently, TNMSC has contracts with 12 laboratories situated all over the country. The top reason for blacklisting products is failure to meet quality standards, an official said. Blacklisting is done for products due to quality failure/non supply and for companies as a whole, for quality failures. According to blacklisting details on TNMSC's website, 'not of standard quality' is the major reason cited for blacklisting a particular drug. 'Purchase orders not executed' and 'substandard quality' are other reasons. In fact, one drug has been blacklisted for the 'presence of an iron piece inside the tablet'. For firms blacklisted from 2024, misbranded drugs is the main reason. Monitoring of warehouses TNMSC's warehouses are monitored through the centralised portal - Drug Distribution Management System - for stock receipt, sampling process, receipt of lab reports, distribution to medical institutions and its fund management. The shelf life expired drugs are disposed through biomedical waste management agencies approved by the T.N. Pollution Control Board once in a year, officials added. As far as equipment is concerned, TNMSC procures only equipment with standardisation certificates such as European CE/US FDA/equivalent Indian standards, they said.
Time of India
18 hours ago
- Time of India
2,426 cr Covid fight bill hit state economy hard: Report
1 2 3 Visakhapatnam: The Covid-19 pandemic not only triggered a public health emergency but also imposed significant financial pressure on the Andhra Pradesh exchequer. Between 2019–20 and 2022–23, the state incurred an expenditure of 4,606 crore on various Covid-19 prevention and management measures, according to the CAG report. Andhra Pradesh was among the hardest-hit states, recording over 23 lakh cases—ranking fifth in the country in terms of case load. In response to the emerging crisis, the state ramped up healthcare infrastructure beginning February 2020. Key initiatives included setting up diagnostic labs, expanding testing capacity, procuring medicines and vaccines, strengthening oxygen supply networks, and mobilizing critical medical resources. Although public health is a state responsibility, the Union Ministry of Health and Family Welfare provided both technical and financial aid to assist states in managing the pandemic. The Centre introduced the Emergency Covid Response Package (ECRP) to curb transmission and mitigate impact. Under ECRP-I, funds released to Andhra Pradesh in FY 2020–21 were fully borne by the Centre. In 2021–22, the funding was shared between Centre and state in a 60:40 ratio. According to the CAG report, during the four-year period, Andhra Pradesh received a total allocation of 4,961.36 crore (both Central and state share) and spent 4,606 crore. Of this, the state govt on its part spent 2,426.47 crore. GoI's share amounted to 1,876.44 crore, of which 1,612.45 crore was utilised. From the state disaster response fund, 140.95 crore was used out of the allocated 187.87 crore. Meanwhile, 426.13 crore was spent from the district mineral fund, against an allocation of 534.41 crore. At the onset of the pandemic in Feb 2020, Andhra Pradesh had no Covid-19 testing infrastructure. The state responded swiftly by establishing 135 testing laboratories. Until these labs became operational, test samples had to be sent to other states for processing. During the second wave, the state expanded the number of Covid-19 treatment hospitals from 260 in the first wave to over 640. It also ramped up human resources, recruiting 17,300 doctors and support staff during the first wave, and an additional 18,000 medical personnel during the second wave. Notably, Andhra Pradesh became one of the few states in India to achieve 100% double-dose vaccination coverage among eligible population groups. In a major welfare initiative, Andhra Pradesh became the first state in the country to include Covid-19 treatment under its flagship Arogyasri health scheme (now renamed as NTR Vaidya Seva). This decision enabled over 1 lakh patients to receive free inpatient treatment at private hospitals across the state.
India Today
a day ago
- India Today
Why healthcare needs to be centre stage in Bihar elections
Hospitals with doctors missing. Operation theatres with equipment missing. Maternity wards with essential drugs missing. This is just the tip of Bihar's healthcare iceberg. As Bihar awaits Assembly elections, let's have a look at why healthcare needs to take centre stage in the man, machine, materialA 2024 CAG report on public health infrastructure and management of health services in Bihar noted that half the posts are empty in the state's health department. The state has one doctor available per 2,148 people, against a recommendation of one doctor per thousand Against specialists' requirement of 5,081, only 1,580 posts were filled in 2024 — 69 per cent of the posts remained vacant. Specifically, in terms of anaesthesia specialists, only 156 were in place, against the requirement of 1,129. While there was a requirement for 911 gynaecology doctors, only 375 were in place. This means 86 per cent of the posts were from lacking human resources, the state also has a scarcity of basic amenities. Drinking water, fans, separate toilets for males and females, chairs, etc., are missing in health centres — as is important equipment in emergency wards and operation theatres!In the sub-district hospitals of Barh, 71 per cent of essential equipment is missing in emergency wards; it's 84 per cent in operation theatres. The situation was found to be similar in Mahua, Makhdumpur, Bhagwanpur, Bakhtiyarpur, and 80 per cent of the essential drugs were missing for maternity services in Barh and Bhagwanpur. The seriousness of maternity conditions can be assessed by the fact that out of 24 cases of maternal deaths reported in 16 test-checked healthcare facilities from FY2016–22, a maternal death review was conducted in only one the physical verification of 25 ambulances showed that none of the ambulances had the required equipment. Also, six test-checked blood banks operated without a valid licence for up to 21 does Bihar's healthcare stand against SDG goals?According to India's Sustainable Development Goals for the United Nations, designed to be achieved by 2030, maternal mortality per lakh live births should be 70. While that number was 97 for the country in 2024, it was 118 for Bihar. Similarly, against a neonatal mortality rate goal of 12 or less, the Indian average was 24.9, and Bihar's was for improvement returnedThe odd thing is that, despite everything, Bihar has not stepped up to improve the healthcare conditions. 'The Government of Bihar had not prepared any comprehensive health policy/ plan, aligned with the National Health Policy, 2017, to address the gaps in infrastructure/equipment in every healthcare facility,' the CAG report said. As a result, the Bihar health department kept returning the money allotted for the financial years 2016 and 2022, a total of Rs 69,791 crore was provisioned for the Bihar health department, of which Rs 21,743 crore or 31 per cent was left report noted that the department kept releasing funds, which remained unutilised and were surrendered on the last day of that financial year.- EndsTune InMust Watch
